Anti-FTCD antibodies are used in the immunodetection of the protein formimidoyltransferase cyclodeaminase. In humans, the canonical protein has a reported length of 541 amino acid residues and a mass of 58.9 kDa. Its subcellular localization is in the Golgi and cytoplasm. Up to 4 different isoforms have been reported for this protein. It is notably expressed in the testis, liver, and kidney. A member of the Cyclodeaminase/cyclohydrolase protein family; Formiminotransferase protein family, FTCD is reported to be a folate-dependent enzyme, that displays both transferase and deaminase activity. The FTCD gene has been associated with the disease, Glutamate formiminotransferase deficiency. Synonyms for this target antigen include LCHC1 and formiminotransferase-cyclodeaminase. FTCD gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Over 100 citations in the literature describe the use of FTCD antibodies in research. Western Blot is a widely used application for these antibodies. In addition, Immunohistochemistry is also a common application.